Cargando…

Environmental Risk Factors and Amyotrophic Lateral Sclerosis (ALS): A Case-Control Study of ALS in Michigan

An interim report of a case-control study was conducted to explore the role of environmental factors in the development of amyotrophic lateral sclerosis (ALS). Sixty-six cases and 66 age- and gender-matched controls were recruited. Detailed information regarding residence history, occupational histo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yu, Su, Feng-Chiao, Callaghan, Brian C., Goutman, Stephen A., Batterman, Stuart A., Feldman, Eva L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076303/ https://www.ncbi.nlm.nih.gov/pubmed/24979055 http://dx.doi.org/10.1371/journal.pone.0101186

Ejemplares similares

Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis
por: Murdock, Benjamin J., et al.
Publicado: (2016)

Associations of self-reported occupational exposures and settings to ALS: a case–control study
por: Goutman, Stephen A., et al.
Publicado: (2022)

Amyotrophic Lateral Sclerosis Survival Associates With Neutrophils in a Sex-specific Manner
por: Murdock, Benjamin J., et al.
Publicado: (2021)

Early life metal dysregulation in amyotrophic lateral sclerosis
por: Figueroa‐Romero, Claudia, et al.
Publicado: (2020)

Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors
por: Sebastião, Ana M., et al.
Publicado: (2018)

Motoneuron firing in amyotrophic lateral sclerosis (ALS)
por: de Carvalho, Mamede, et al.
Publicado: (2014)

Saccadic intrusions in amyotrophic lateral sclerosis (ALS)
por: Becker, Wolfgang, et al.
Publicado: (2019)

Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts
por: Goutman, Stephen A, et al.
Publicado: (2022)

Alterations in Leptin Signaling in Amyotrophic Lateral Sclerosis (ALS)
por: Ferrer-Donato, Agueda, et al.
Publicado: (2021)

Dysregulated biodynamics in metabolic attractor systems precede the emergence of amyotrophic lateral sclerosis
por: Curtin, Paul, et al.
Publicado: (2020)

Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS)
por: Mavlyutov, Timur A., et al.
Publicado: (2015)

Amyotrophic Lateral Sclerosis (ALS) Awareness Month — May 2013
Publicado: (2013)

Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design
por: Fournier, Christina N.
Publicado: (2022)

Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy
por: Seki, Soju, et al.
Publicado: (2023)

Tofacitinib Suppresses Natural Killer Cells In Vitro and In Vivo: Implications for Amyotrophic Lateral Sclerosis
por: Figueroa-Romero, Claudia, et al.
Publicado: (2022)

ALS2 mutations: Juvenile amyotrophic lateral sclerosis and generalized dystonia
por: Sheerin, Una-Marie, et al.
Publicado: (2014)

Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
por: Albanese, Alberto, et al.
Publicado: (2022)

State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance
por: Wagner, Laurie, et al.
Publicado: (2016)

Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?
por: Trojsi, Francesca, et al.
Publicado: (2020)

Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients
por: Park, Jin-Mo, et al.
Publicado: (2019)

MRI Study of Paraspinal Muscles in Patients with Amyotrophic Lateral Sclerosis (ALS)
por: Diamanti, Luca, et al.
Publicado: (2020)

The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS)
por: Ferrer‐Donato, Agueda, et al.
Publicado: (2021)

Delivery of nutritional management services to people with amyotrophic lateral sclerosis (ALS)
por: Halliday, Vanessa, et al.
Publicado: (2021)

Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis
por: Foerster, Bradley R, et al.
Publicado: (2014)

Disease propagation in amyotrophic lateral sclerosis (ALS): an interplay between genetics and environment
por: Schram, Sarah, et al.
Publicado: (2020)

Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?
por: Mentis, Alexios-Fotios A., et al.
Publicado: (2021)

Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis
por: Figueroa-Romero, Claudia, et al.
Publicado: (2012)

Personalized Medicine and Molecular Interaction Networks in Amyotrophic Lateral Sclerosis (ALS): Current Knowledge
por: Morgan, Stephen, et al.
Publicado: (2018)

The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS)
por: Boddy, Sarah L., et al.
Publicado: (2021)

Environmental insults: critical triggers for amyotrophic lateral sclerosis
por: Yu, Bing, et al.
Publicado: (2017)

Incidence and Geographical Variation of Amyotrophic Lateral Sclerosis (ALS) in Southern Germany – Completeness of the ALS Registry Swabia
por: Uenal, Hatice, et al.
Publicado: (2014)

Extracellular Vesicles in Serum and Central Nervous System Tissues Contain microRNA Signatures in Sporadic Amyotrophic Lateral Sclerosis
por: Lo, Ting-wen, et al.
Publicado: (2021)

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
por: Yunusova, Yana, et al.
Publicado: (2011)

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2014)

Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)
por: Limpert, Allison S, et al.
Publicado: (2013)

Profiling Speech and Pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
por: Yunusova, Yana, et al.
Publicado: (2016)

Omics Approach to Axonal Dysfunction of Motor Neurons in Amyotrophic Lateral Sclerosis (ALS)
por: Suzuki, Naoki, et al.
Publicado: (2020)

Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
por: García-García, Raquel, et al.
Publicado: (2021)

Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models
por: Maksimovic, Katarina, et al.
Publicado: (2023)

Detecting bulbar amyotrophic lateral sclerosis (ALS) using automatic acoustic analysis
por: Simmatis, Leif, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5m09h6dj87v67rsja1esspr933